The tumor organoids were successfully established, which was demonstrated by morphology and immunohistochemistry staining (estrogen receptor [ER], progesterone receptor [PR], and human epidermal growth factor receptor‐2 [HER2]) compared to the primary pathological patterns (Figure 1B). This evidence concerns the gene ERBB2 and neoplasm.